| Randall L Miller, MD | |
|
4439 State Route 159, Suite 130, Chillicothe, OH 45601-8207 | |
| (740) 779-4360 | |
| (740) 779-4369 |
| Full Name | Randall L Miller |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
| Location | 4439 State Route 159, Chillicothe, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639144637 | NPI | - | NPPES |
| 0665409 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 35055086 (Ohio) | Primary |
| Entity Name | Adena Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235468083 PECOS PAC ID: 1153456579 Enrollment ID: O20100323001007 |
News Archive
WHO urges countries to protect the rights and dignity of people with mental health conditions as it launches a new tool for countries to assess and eventually stop, these violations. The WHO QualityRights Tool Kit aims to ensure that quality of care and human rights standards are put in place in mental health and social care facilities around the world.
A team led by a scientist from the Florida campus of The Scripps Research Institute has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
Emergency room practitioners can be successfully trained in two hours to counsel problem drinkers in a 10-minute intervention, according to a study by Yale researchers in Academic Emergency Medicine.
Emisphere Technologies, Inc. today announced study results demonstrating that a single dose of the novel oral parathyroid hormone PTH1-34, which utilizes Emisphere's proprietary Eligen® Drug Delivery Technology and absorption-enhancer carrier molecule 5-CNAC, achieved potentially therapeutically relevant exposure and safety profiles to those of the currently available injectable formulation in healthy postmenopausal women.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randall L Miller, MD 4439 State Route 159, Suite 130, Chillicothe, OH 45601-8207 Ph: (740) 779-4360 | Randall L Miller, MD 4439 State Route 159, Suite 130, Chillicothe, OH 45601-8207 Ph: (740) 779-4360 |
News Archive
WHO urges countries to protect the rights and dignity of people with mental health conditions as it launches a new tool for countries to assess and eventually stop, these violations. The WHO QualityRights Tool Kit aims to ensure that quality of care and human rights standards are put in place in mental health and social care facilities around the world.
A team led by a scientist from the Florida campus of The Scripps Research Institute has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
Emergency room practitioners can be successfully trained in two hours to counsel problem drinkers in a 10-minute intervention, according to a study by Yale researchers in Academic Emergency Medicine.
Emisphere Technologies, Inc. today announced study results demonstrating that a single dose of the novel oral parathyroid hormone PTH1-34, which utilizes Emisphere's proprietary Eligen® Drug Delivery Technology and absorption-enhancer carrier molecule 5-CNAC, achieved potentially therapeutically relevant exposure and safety profiles to those of the currently available injectable formulation in healthy postmenopausal women.
› Verified 1 days ago
Ethelbert Jackson Baker, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159, Suite 130, Chillicothe, OH 45601 Phone: 740-779-4360 Fax: 740-779-4369 |